Abstract: A unit dose capsule for use with a sonic generator includes a deformable membrane adapted to releasably engage the distal end of the elongate horn, a nozzle including at least one delivery opening; a nozzle including at least one delivery opening; and a reservoir containing a liquid composition disposed therebetween. When the unit dose capsule is engaged to the distal end of the elongate horn, the nozzle is disposed in an outwardly facing orientation, and the reservoir is in liquid communication with the at least one nozzle. The unit dose capsule can be included in a kit with a handheld misting device comprising a housing having a dispensing window arranged and configured to contain a sonic generator and a power source.
Abstract: A personal hygiene device may have a main body with an absorbent material configured to absorb a fluid, a sensor disposed within the main body, and a controller configured to communicate with the sensor. The sensor has a conductor and an insulator containing at least a portion of the conductor, and the sensor is configured to detect a first electrical value and a second electrical value that is different from the first electrical value. The sensor is also configured to transmit a signal to the controller upon detection of the second electrical value.
Type:
Grant
Filed:
August 21, 2018
Date of Patent:
February 21, 2023
Assignee:
Johnson & Johnson Consumer Inc.
Inventors:
William Chester Neeley, Randall B. Pugh, Adam Toner
Abstract: A dosage form comprising a tablet core and one or more discontinuous coated regions in various configurations on the surface of the dosage form is disclosed. A method for making the dosage form is also disclosed.
Type:
Grant
Filed:
January 28, 2020
Date of Patent:
February 14, 2023
Assignee:
Johnson & Johnson Consumer Inc.
Inventors:
Harry Sowden, Gerard McNally, Der-Yang Lee
Abstract: A handheld misting device has a housing having a dispensing window is arranged and configured to contain a sonic generator, a power source coupled to the sonic generator, a plurality of reservoirs, each containing a liquid, and a plurality of nozzles, each nozzle arranged and configured for removable coupling to the sonic generator. Each nozzle is associated with and in liquid communication with a single reservoir. The sonic generator includes a converter and an elongate horn having a proximal end coupled to the converter and a distal end, and the nozzle is removably coupled to the distal end of the horn. Thus, the device delivers the liquid through a delivery opening formed in the nozzle, and activating the sonic generator energizes the liquid in the nozzle to generate an aerosol plume that is delivered through the dispensing window.
Abstract: A device for dispensing a fluid topical composition includes a reservoir storing the composition and dispensing a pressurized flow of the composition. The device also includes an accumulator having an expandable chamber in fluidly communication with the reservoir. The chamber is biased towards a deflated configuration so that, when filled with the composition the chamber expands against this bias applying pressure to the composition stored therein. The device includes a supply valve regulating the flow of the composition from the reservoir to the accumulator, and a pressure sensor. The device further includes a processing arrangement analyzing data from the sensor to determine whether pressure in the accumulator is above a predetermined threshold and controlling the supply valve to maintain the pressure within a desired pressure range. The device also includes a deposition arrangement dispensing the composition from the accumulator under control of the processing arrangement.
Abstract: A cleansing composition and method of using a cleansing composition, the cleansing composition including a blend of three different emollients, the emollients including a first stearic ester, a second stearic ester, and a branched hydrocarbon, where the first stearic ester and second stearic ester are different from each other.
Abstract: A dermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.
Abstract: In one aspect, the present invention features an emulsion composition including (i) at least 3%, by weight, of a nonsteroidal anti-inflammatory drug; (ii) at least 15%, by weight, of isopropyl myristate; (iii) at least 25%, by weight, of water; and (iv) one or more emulsifiers; wherein the formulation is substantially free of C1-C4 alcohols.
Abstract: A liquid oral pharmaceutical dosage form, comprising pharmacologically effective amounts of at least one histamine H2-receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water comprising at least one viscosity enhancing agent, and pharmacologically effective amounts of one or more antacid(s) in a liquid comprising at least one viscosity enhancing agent and at least one flavor, wherein the two liquids are physically separated from each other and wherein the two liquids have matching rheological profiles and a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.
Type:
Grant
Filed:
April 24, 2019
Date of Patent:
September 6, 2022
Assignee:
Johnson & Johnson Consumer Inc.
Inventors:
Salih Muhsin Muhammed, Katarina Lindell, Jill Nilgard, Sofi Nöjd
Abstract: A transdermal delivery device includes a film having first and second outwardly facing major surfaces; at least one liquid reservoir contained within the film; at least one microfluidic channel having a transverse dimension between about 100 nm and 0.5 mm disposed within the film and in fluid communication with the at least one liquid reservoir; and at least one outlet port associated with at least one microneedle operatively connected to the first outwardly facing major surface of the film in fluid communication with the at least one microfluidic channel.